HIV-induced immunopathogenesis

Immunity

Volumn 9, Issue 5, 1998, Pages 587-593

  Shearer, Gene M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LYMPHOCYTE DEPLETION; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION;

EID: 0032212941     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80656-1     Document Type: Review

References (60)

1. Ameisen, J.-C., and Capron, A. (1991). Cell dysfunction and depletion in AIDS: the programmed cell death hypotheses. Immunol. Today 12, 102-105.
2. Ascher, M.S., and Sheppard, H.W. (1988). AIDS as immune system activation: a model for pathogenesis. Clin. Exp. Immunol. 73, 165-167.
3. Badley, A.D., McElhinny, J.A., Leibson, P.J., Lynch, D.H., Alderson, M.R., and Paya, C.V. (1996). Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70, 199-206.
4. Badley, A.D., Dockrell, D., Simpson, M., Schut, R., Lynch, D.H., Leibson, P., and Paya, C.V. (1997). Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185, 55-64.
5. Badley, A.D., Dockrell, D.H., Algeciras, A., Ziesmer, S., Landay, A., Lederman, M.M., Connick, E., Kessler, H., Kuritzkes, D., Lynch, D.H., et al. (1998). In vivo analysis of Fas/FasL interactions in HIV-infected patients. J. Clin. Invest. 102, 79-87.
6. Chougnet, C., Clerici, M., and Shearer, G.M. (1996). Role of IL-12 in HIV disease/AIDS. Res. Immunol. 147, 615-622.
7. Chougnet, C., Thomas, E., Landay, A.L., Kessler, H.A., Buchbinder, S., Scheer, S., and Shearer, G.M. (1998). CD40 ligand and IFN-γ synergistically restore IL-12 production in HIV-infected patients. Eur. J. Immunol. 28, 646-656.
8. Clerici, M., and Shearer, G.M. (1993). TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14, 107-111.
9. Clerici, M., and Shearer, G.M. (1994). The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15, 575-581.
10. Clerici, M., Stocks, N.I., Zajac, R.A., Boswell, R.N., Bernstein, D.C., Mann, D.L., Shearer, G.M., and Berzofsky, J.A. (1989). Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 339, 383-385.
11. Clerici, M., Landay, A., Kessler, H.A., Zajac, R.A., Boswell, R.N., Muluk, S.C., and Shearer, G.M. (1991). Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. J. Immunol. 146, 2207-2213.
12. Clerici, M., Balotta, C., Meroni, L., Ferrario, E., Riva, C., Trabattoni, D., Ridolfo, A., Villa, M., Shearer, G.M., Moroni, M., and Galli, M. (1996a). Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. AIDS Res. Hum. Retro. 12, 1053-1061.
13. Clerici, M., Sarin, A., Berzofsky, J.A., Landay, A.L., Kessler, H.A., Hashemi, F., Hendrix, C.W., Blatt, S.P., Rusnak, J., Dolan, M.J., et al. (1996b). Antigen-stimulated apoptotic T cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS 10, 603-611.
14. Clerici, M., Sarin, A., Henkart, P.A., and Shearer, G.M. (1997). Apoptotic cell death and cytokine dysregulation in human immunodeficiency virus infection: pivotal factors in disease progression. Cell Death Differ. 4, 699-706.
15. Cottrez, F., Manca, F., Dalgleish, A.G., Arenzana-Seisdedos, F., Capron, A., and Groux, H. (1997). Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule. J. Clin. Invest. 99, 257-266.
16. Dockrell, D.H., Badley, A.D., Vallacian, J.S., Heppelmann, C.J., Algeciras, A., Ziesmer, S., Yagita, H., Lynch, D.H., Roche, P.C., Leibson, P.J., and Paya, C.V. (1998). The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. J. Clin. Invest. 101, 2394-2405.
17. Dolan, M.J., Clerici, M., Blatt, S.P., Hendrix, C.W., Melcher, G.P., Boswell, R.N., and Shearer, G.M. (1995). A functional and phenotypic assessment of T-helper cells in HIV-1 infected patients offers independent prognostic information for survival. J. Infect. Dis. 172, 79-87.
18. Dudhane, A., Conti, B., Orlikowsky, T., Wang, Z.Q., Mangla, N., Gupta, A., Wormser, G.P., and Hoffmann, M.K. (1996a). Monocytes in HIV type-1 infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity. AIDS Res. Hum. Retro. 12, 885-892.
19. Dudhane, A., Wang, Z.Q., Orlikowsky, T., Gupta, A., Wormser, G.P., Horowitz, H., Kufer, P., and Hoffmann, M.K. (1996b). AIDS patient monocytes target CD4 T cells for cellular conjugate formation and deletion through the membrane expression of HIV-1 envelope molecules. AIDS Res. Hum. Retro. 12, 893-899.
20. Ennen, J., Seipp, I., Norley, S.G., and Kurth, R. (1990). Decreased accessory cell function of macrophages after infection with human immunodeficiency virus type 1 in vitro. Eur. J. Immunol. 20, 2451-2456.
21. Finkel, T.H., and Banda, N.K. (1994). Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells? Curr. Opin. Immunol. 6, 605-615.
22. Finkel, T.H., Tudor-Williams, G., Banda, N.K., Cotton, M.F., Curiel, T., Monks, C., Baba, T.W., Ruprecht, R.M., and Kupfer, A. (1995). Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nat. Med. 1, 129-134.
23. Fuchs, D., Hausen, A., Reibnegger, G., Werner, E.R., Dierich, M.P., and Wachter, H. (1988). Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol. Today 9, 150-155.
24. Giorgi, J.V., Liu, Z., Hultin, L.E., Cumberland, W.G., Hennessey, K., and Detels, R. (1993). Elevated levels of CD38+CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. J. Acq. Imm. Def. Syn. 6, 904-912.
25. Gottlieb, M.S., Groopman, J.E., Weinstein, W.M., Fahey, J.L., and Detels, R. (1983). The acquired immunodeficiency syndrome. Ann. Intern. Med. 99, 208-220.
26. Gulick, R.M., Mellors, J.W., Havlir, D., Eron, J.J., Gonzalez, C., McMahon, D., Richman, D.D., Valentine, F.T., Jonas, L., Meibohm, A., et al. (1997). Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337, 734-739.
27. Heath, S.L., Tew, J.G., Tew, J.G., Szakal, A.K., and Burton, G.F. (1995). Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377, 740-744.
28. Herbein, G., Van Lint, C., Lovett, J.L., and Verdin, E. (1998). Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J. Virol. 72, 660-670.
29. Ho, H.-N., Hultin, L.E., Mitsuyasu, R.T., Matud, J.L., Hausner, M. A., Bockstoce, D, Chou, C.-C., O'Rourke, S., Taylor, J.M.G., and Giorgi, J.V. (1993). Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J. Immunol. 150, 3070-3079.
30. β sequences. Science 254, 860-862.
31. Koup, R.A., Safrit, J.T., Cao, Y., Andrews, C.A., McLeod, G., Borkowsky, W., Farthing, C., and Ho, D. (1994). Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650-4655.
32. Levy, J.A. (1993). Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183-289.
33. Levy, J.A. (1998). HIV and the Pathogenesis of AIDS, Second Edition (Washington, DC: American Society of Microbiology).
34. Maggi, E., Mazzetti, M., Ravina, A., Annunziato, F., de Carli, M., Piccinni, M.P., Manetti, R., Carbonari, M., Pesce, A.M., del Prete, G., and Romagnani, S. (1994). Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265, 244-248.
35. Mazzoli, S., Trabattoni, D., Lo Caputo, S., Piconi, S., Ble, C., Meacci, F., Ruzzante, S., Salvi, A., Semplici, F., Longhi, R., et al. (1997). HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3, 1250-1257.
36. McMichael, A.J., and Phillips, R.E. (1997). Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15, 271-296.
37. Meyaard, L., Schuitemaker, H., and Miedema, F. (1993). T-cell dysfunction in HIV-infection - anergy due to defective antigen-presenting cell-function. Immunol. Today 14, 161-164.
38. Miedema, F., Meyaard. L., Koot, M., Klein, M.R., Roos, M.Th.L., Groenink, M., Fouchier, R.A.M., Vant Wout, A.B., Tersmette, M., Schellekens, P.Th.A., and Schuitemaker, H. (1994). Changing virus-host interactions in the course of HIV-1 infection. Immunol. Rev. 140, 35-72.
39. Mikovits, J.A., Young, H.A., Vertino, P., Issa, J.-P.J., Pitha, P.M., Turcoski-Corrales, S., Taub, D.D., Petrow, C.L., Baylin, S.B., and Ruscetti, F.W. (1998). Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma Interferon (IFN-γ) promoter and subsequent downregulation of IFN-γ production. Mol. Cell. Biol. 18, 5166-5177.
40. Mosmann, T.R., and Coffman, R.L. (1989). Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
41. Oyaizu, N., and Pahwa, S. (1995). Role of apoptosis in HIV disease pathogenesis. J. Clin. Immunol. 15, 217-231.
42. Pantaleo, G., and Fauci, A.S. (1995). New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 13, 487-512.
43. Pericle, F., Pinto, L.A., Hicks, S., Kirken, R.A., Sconocchia, G., Rusnak, J., Dolan, M.J., Shearer, G.M., and Segal, D. (1998). HIV-1 infection induces a selective reduction in STATS protein expression. J. Immunol. 160, 28-31.
44. Polyak, S., Chen, H., Hirsch, D., George, I., Hershberg, R., and Sperber, K. (1997). Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J. Immunol. 759, 2177-2188.
45. Prince, H.E., Kermani-Arab, B., and Fahey, J.L. (1984). Depressed interleukin-2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes. J. Immunol. 133, 1313-1317.
46. Ramsdell, F., Seaman, M.S., Miller, R.E., Picha, K.S., Kennedy, M.K., and Lynch, D.H. (1994). Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 10, 1545-1553.
47. Roederer, M., Dubs, J.G., Anderson, M.T., Raju, P.A., Herzenberg, L.A., and Herzenberg, L.A. (1995). CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95, 2061-2066.
48. Romagnani, S. (1991). Human TH1 and TH2 subsets: doubt no more. Immunol. Today 12, 256-258.
49. Rook, A.H., Mazur, H., Lane, L.C., Frederick, W., Kasahara, T., Macher, A.M., Djeu, J.Y., Manischewitz, J.F., Jackson, L., Fauci, A.S., and Quinnan, G.V., Jr. (1983). Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activity of lymphocytes from patients with the acquired immunodeficiency syndrome. J. Clin. Invest. 72, 398-403.
50. Rosenberg, E.S., Billingsley, J.M., Caliendo, A.M.,. Boswell, S.L., Sax, P.E., Kalams, S.A., and Walker, B.D. (1997). Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447-1450.
51. Rossio, J.L., Bess, J., Jr., Henderson, L.E., Creswell, P., and Arthur, LO. (1995). HLA class II on HIV particles is functional insuperantigen presentation to human T cells: implications for HIV pathogenesis. AIDS Res. Hum. Retrov. 11, 1433-1439.
52. Rowland-Jones, S.L., and McMichael, A. (1995). Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr. Opin. Immunol. 7, 448-455.
53. Shearer, G.M., and Clerici, M. (1996a). Type 1 and type 2 responses in HIV infection and exposure. In Immunology of HIV Infection, S. Gupta, ed. (New York: Plenum Press), pp. 229-241.
54. Shearer, G.M., and Clerici, M. (1996b). Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17, 21-24.
55. Varadhachary, A.S., Perdow, S.N., Hu, C., Ramanarayanan, M., and Salgame, P. (1997). Differential ability of T cell subsets to undergo activation-induced cell death. Proc. Natl. Acad. Sci. USA 94, 5778-5783.
56. Vyakarnam, A., Matear, P.M., Martin, S.J., and Wagstaff, M. (1995). Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells. Immunology 86, 85-96.
57. Westby, M., Manca, F., and Dalgleish, A.G. (1996). The role of host immune responses in determining the outcome of HIV infection. Immunol. Today 17, 120-126.
58. Yoo, J., Chen, H., Kraus, D., Hirsch, D., Polyak, S., George, I., and Sperber, K. (1996). Altered cytokine production and accessory cell function after HIV-1 infection. J. Immunol. 157, 1313-1320.
59. Zinkernagel, R.M., and Hengartner, H. (1994). T-cell mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol. Today 15, 262-268.
60. Zwilling, B.S., Salkowitz, J., Laufman, H., and Pearl, D. (1991). Differences in the expression of histocompatibility antigen-DR and in antimycobacterial activity of monocytes from HIV-infected individuals. AIDS 5, 1327-1332.